Mounjaro®
Starting from £179.99/mo
Start journey Learn moreIf you've searched for 5ml tirzepatide, you're most likely trying to work out what the liquid volume in a Mounjaro KwikPen actually means — whether a pen labelled by its strength in milligrams also carries 5ml of solution, and what that tells you about your doses. Each Mounjaro pen contains 3ml of solution, not 5ml. The 5ml figure sometimes circulates in online discussions but does not correspond to any licensed Mounjaro presentation in the UK. Tirzepatide is a prescription-only medicine and a prescriber, not a measurement conversion, determines the dose and pen strength that suits you.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
The confusion is understandable. Many injectable medicines are described by their fill volume, a 5ml vial is a standard size in pharmacy, and people who research their treatment carefully often encounter volume measurements in manufacturer documentation, clinical trial papers, or informal forums. When those figures get copied and circulated, they can attach themselves to medicines where they simply do not apply.
Mounjaro, the branded form of tirzepatide available in the UK, is dispensed in a pre-filled KwikPen containing 3ml of solution. Each pen is designed to deliver four weekly injections of 0.5ml each, 4 × 0.5ml = 2ml of active solution used in total, with a small overfill retained in the device. A 5ml fill volume has no place in that design. If you have seen a seller describe tirzepatide in a 5ml format, that is a significant red flag: it does not match the licensed presentation, and the MHRA has warned publicly about fake weight-loss pens that bear no resemblance to the genuine article. Suspected sellers can be reported at the MHRA Yellow Card service.
The number to pay attention to on your pen is the milligram strength, not the fill volume. That is what the prescriber is working from when they decide which pen is right for you at a given stage of treatment.
Tirzepatide is available in the UK at six strengths: 2.5mg, 5mg, 7.5mg, 10mg, 12.5mg and 15mg. The figure on the pen label is the total amount of tirzepatide delivered across all four weekly doses in that pen, so a 5mg pen, for instance, provides four doses of 1.25mg each. The concentration is expressed per 0.5ml injection.
Treatment starts at 2.5mg regardless of target dose. The first pen's job is to let your system adjust to the medicine rather than to produce immediate weight loss. After four weeks, and subject to how you are tolerating it, the prescriber will typically move you to the next rung. More detail on the Mounjaro 5mg pen (which is commonly the second step in the titration schedule) is worth reading if you are approaching that stage.
The licensed pathway up to 15mg reflects the evidence from the SURMOUNT clinical programme, where participants on the highest doses achieved meaningful reductions in body weight over 72 weeks, as reported in the SURMOUNT-1 trial in the New England Journal of Medicine. Dose increases are always a clinical decision, they are not automatic, and a prescriber reviews progress and tolerance before any change is made.
Practically speaking, the 3ml fill volume has no bearing on your day-to-day routine beyond the fact that one pen lasts you four weeks. Storage is refrigerated at 2–8°C. The Patient Information Leaflet that comes with your pen covers the exact room-temperature window if you are travelling or your fridge is temporarily unavailable, it is worth reading that section rather than relying on a figure found online, because the window is specific to the concentration and formulation.
Injection technique is straightforward: the KwikPen is used at the abdomen, thigh or upper arm, rotating the site each week. The volume per injection is 0.5ml, small enough that most people find the process less intimidating than they expected. The pen itself handles dose metering; you do not draw up or measure anything.
If you keep your pen in the fridge door rather than the main compartment, just check it has not been exposed to freezing, frozen tirzepatide solution should not be used. That is one of the practical details a prescriber will cover during your initial consultation, and you can find further guidance on our tirzepatide information page if you want to read ahead before that conversation.
Yes. Tirzepatide is licensed for private prescription in the UK for adults with a BMI of 30 or above, or 27 or above alongside a weight-related health condition, lower thresholds apply for some ethnic backgrounds under NICE guidance. A prescriber assesses the complete clinical picture, not just a single number. You can explore the full Mounjaro overview for more on what the medicine involves, and what private treatment costs in the UK context, including what a legitimate quoted price should include.
What matters most when sourcing a prescription-only medicine online is verifying that the pharmacy is real. Any GPhC-registered pharmacy can be confirmed on the GPhC pharmacy register, checking takes about thirty seconds. At nume, every consultation is read by a GPhC-registered Independent Prescriber the same day; your prescription is written by a person, not generated by software. You can read more about who we are and how the service works, or browse the wider range of weight-loss treatment options if you are still at the comparison stage.
When you are ready to take the next step, speak to our prescribers through a free consultation, there is no obligation, and the process is designed to be straightforward.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.